Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition

In conclusion, PPT2 is downregulated in ccRCC. Decreased PPT2 expression may be considered as a novel diagnostic marker and prognostic factor and serve as a therapeutic target for ccRCC.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: ChangFei Yuan, ZhiYong Xiong, Jian Shi, JingTao Peng, XianGui Meng, Cheng Wang, WenJun Hu, ZeYuan Ru, KaiRu Xie, HongMei Yang, Ke Chen, XiaoPing Zhang Tags: Research Paper Source Type: research